Publicacions en col·laboració amb investigadors/es de Erasmus University Medical Center (51)

2024

  1. Correction to: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)

    Nature Reviews Cardiology

2023

  1. Coronary Lithotripsy as Elective or Bail-Out Strategy After Rotational Atherectomy in the Rota-Shock Registry

    American Journal of Cardiology, Vol. 198, pp. 1-8

2022

  1. Coronary lithotripsy for the treatment of underexpanded stents: the international & multicentre CRUNCH registry

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 7, pp. 574-581

  2. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

  3. Optical coherence tomography in coronary atherosclerosis assessment and intervention

    Nature Reviews Cardiology, Vol. 19, Núm. 10, pp. 684-703

2021

  1. Age and functional relevance of coronary stenosis: A post hoc analysis of the ADVISE II trial

    EuroIntervention, Vol. 17, Núm. 9, pp. 757-764

  2. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with european society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group

    EuroIntervention, Vol. 16, Núm. 13, pp. 1049-1069

  3. Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome

    International Journal of Cardiology, Vol. 336, pp. 22-28

2020

  1. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group

    European Heart Journal, Vol. 41, Núm. 37, pp. 3504-3520

  2. Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: The COMPAREABSORB randomised clinical trial

    EuroIntervention, Vol. 16, Núm. 8, pp. 645-653

  3. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction

    Cardiovascular Research, Vol. 116, Núm. 4, pp. 787-805

  4. Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST-Segment-Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long-Term Follow-Up of the REDUCE-MVI Trial

    Journal of the American Heart Association, Vol. 9, Núm. 5, pp. e014411

  5. The Impact of Coronary Physiology on Contemporary Clinical Decision Making

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 14, pp. 1617-1638

  6. Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study

    Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 1, pp. 10-17

2019

  1. Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial

    Cardiovascular Revascularization Medicine, Vol. 20, Núm. 7, pp. 577-582

  2. Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 3, pp. 259-270

  3. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 20, pp. 2064-2075

  4. Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study

    EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252

  5. Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment-Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel: The REDUCE-MVI Trial

    Circulation, Vol. 139, Núm. 5, pp. 636-646

  6. Impact of post-procedural minimal stent area on 2-year clinical outcomes in the SYNTAX II trial

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 4, pp. E225-E234